Molecular Techniques and Gene Mutations in Myelodysplastic Syndromes

被引：2
|
作者：
Mendoza, Hadrian [1 ]
Siddon, Alexa J. [2 ,3 ,4 ]
机构：
[1] Yale Sch Med, Dept Internal Med, POB 208030, New Haven, CT 06520 USA
[2] Yale Sch Med, Dept Lab Med, New Haven, CT USA
[3] Yale Sch Med, Dept Pathol, New Haven, CT USA
[4] Yale Sch Med, Dept Lab Med, 330 Cedar St,POB 208035, New Haven, CT 06520 USA
来源：
CLINICS IN LABORATORY MEDICINE | 2023年 / 43卷 / 04期
关键词：
Mutations; Myelodysplastic syndromes; Myelodysplasia; Next-generation sequencing; Whole-genome sequencing; ACUTE MYELOID-LEUKEMIA; BIOLOGICAL IMPLICATIONS; COHESIN COMPLEX; WHOLE GENOME; RISK; CLASSIFICATION; POPULATION; LANDSCAPE; EVOLUTION; VARIANTS;
D O I：
10.1016/j.cll.2023.06.002
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
[No abstract available]
引用
收藏
页码：549 / 563
页数：15
相关论文
共 50 条
  • [21] RELATION BETWEEN MOLECULAR MUTATIONS AND ABERRANTLY EXPRESSED ANTIGENS IN MYELODYSPLASTIC SYNDROMES
    Kern, W.
    Ogawa, S.
    Haferlach, C.
    Schnittger, S.
    Haferlach, T.
    LEUKEMIA RESEARCH, 2015, 39 : S110 - S110
  • [22] Somatic Gene Mutations Serve As Molecular Biomarkers Predictive for Response to Immunosuppressive Therapy (IST) in Myelodysplastic Syndromes (MDS)
    Komrokji, Rami S.
    Haider, Mintallah
    Al Ali, Najla H.
    Lancet, Jeffrey E.
    Zhang, Qing
    Epling-Burnette, Pearlie K.
    List, Alan F.
    Padron, Eric
    BLOOD, 2015, 126 (23)
  • [23] Point Mutations in Myelodysplastic Syndromes REPLY
    Bejar, Rafael
    Ebert, Benjamin L.
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (12): : 1155 - 1155
  • [24] Mutations of myelodysplastic syndromes (MDS): An update
    Ganguly, Bani Bandana
    Kadam, N. N.
    MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH, 2016, 769 : 47 - 62
  • [25] Mutations in epigenetic regulators in myelodysplastic syndromes
    Nikoloski, Gorica
    van der Reijden, Bert A.
    Jansen, Joop H.
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2012, 95 (01) : 8 - 16
  • [26] Mutations in epigenetic regulators in myelodysplastic syndromes
    Gorica Nikoloski
    Bert A. van der Reijden
    Joop H. Jansen
    International Journal of Hematology, 2012, 95 : 8 - 16
  • [27] GENE MUTATIONS AND MICRORNA SIGNATURE IN MYELODYSPLASTIC SYNDROMES DURING AZACITIDINE AND LENALIDOMIDE THERAPY
    Follo, M. Y.
    Pellagatti, A.
    Armstrong, R. N.
    Ratti, S.
    Mongiorgi, S.
    Astolfi, A.
    Indio, V.
    De Fanti, S.
    Russo, D.
    Gobbi, M.
    Miglino, M.
    Bochicchio, M. T.
    Martinelli, G.
    Parisi, S.
    Pession, A.
    Cavo, M.
    Cocco, L.
    Manzoli, L.
    Boultwood, J.
    Finelli, C.
    HAEMATOLOGICA, 2018, 103 : S43 - S44
  • [28] Incidence of HFE gene mutations in Chinese patients with myelodysplastic syndromes and aplastic anemia
    Xiao, Z.
    Nie, L.
    Yang, L.
    LEUKEMIA RESEARCH, 2009, 33 : S101 - S101
  • [29] NEW GERMLINE TERT GENE MUTATIONS IN APLASTIC ANEMIA/HYPOCELLULAR MYELODYSPLASTIC SYNDROMES
    Matteucci, C.
    Iannotti, T.
    Nofrini, V.
    Brandimarte, L.
    Pierini, V.
    Barba, G.
    Di Battista, V.
    Arcioni, F.
    La Starza, R.
    Aversa, F.
    Mecucci, C.
    HAEMATOLOGICA, 2014, 99 : 85 - 86
  • [30] Somatic mutations of the histone methyltransferase gene EZH2 in myelodysplastic syndromes
    Gorica Nikoloski
    Saskia M C Langemeijer
    Roland P Kuiper
    Ruth Knops
    Marion Massop
    Evelyn R L T M Tönnissen
    Adrian van der Heijden
    Theresia N Scheele
    Peter Vandenberghe
    Theo de Witte
    Bert A van der Reijden
    Joop H Jansen
    Nature Genetics, 2010, 42 : 665 - 667
12345